Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding

Journal of Cell Science

Volumn 118, Issue 21, 2005, Pages 5119-5128

  Tzircotis, George ^a   Thorne, Rick F ^a,b   Isacke, Clare M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Breast cancer; CD44; Chemotaxis; Hyaluronan; Migration

Indexed keywords

CHEMOATTRACTANT; HERMES ANTIGEN; HYALURONIC ACID; LIGAND; OLIGONUCLEOTIDE; SMALL INTERFERING RNA;

ANTIGEN EXPRESSION; ARTICLE; ASSAY; BINDING AFFINITY; BREAST CANCER; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL STRAIN 3T3; CELL TYPE; CHEMOTAXIS; CONTROLLED STUDY; DATA ANALYSIS; DOWN REGULATION; EXTRACELLULAR MATRIX; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD44; BREAST NEOPLASMS; CELL LINE, TUMOR; CHEMOTAXIS, LEUKOCYTE; DETERGENTS; FIBROBLASTS; HUMANS; HYALURONIC ACID; MEMBRANE MICRODOMAINS; MICE; MICROSCOPY, CONFOCAL; MOLECULAR WEIGHT; NIH 3T3 CELLS; PROTEIN BINDING; SOLUBILITY; TRANSFECTION;

BOVINAE;

EID: 27944463584     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02629     Document Type: Article

References (70)

1. Allen, W. E., Zicha, D., Ridley, A. J. and Jones, G. E. (1998). A role for Cdc42 in macrophage chemotaxis. J. Cell Biol. 141, 1147-1157.
2. Anttila, M. A., Tammi, R. H., Tammi, M. I., Syrjanen, K. J., Saarikoski, S. V. and Kosma, V. M. (2000). High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res. 60, 150-155.
3. Auvinen, P., Tammi, R., Parkkinen, J., Tammi, M., Agren, U., Johansson, R., Hirvikoski, P., Eskelinen, M. and Kosma, V. M. (2000). Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am. J. Pathol. 156, 529-536.
4. Bartolazzi, A., Nocks, A., Aruffo, A., Spring, F. and Stamenkovic, I. (1996). Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J. Cell Biol. 132, 1199-1208.
5. Bennett, K. L., Modrell, B., Greenfield, B., Bartolazzi, A., Stamenkovic, I., Peach, R., Jackson, D. G., Spring, F. and Aruffo, A. (1995). Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol. 131, 1623-1633.
6. Bourguignon, L. Y., Singleton, P. A., Diedrich, F., Stern, R. and Gilad, E. (2004). CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J. Biol. Chem. 279, 26991-27007.
7. Day, A. J. and Prestwich, G. D. (2002). Hyaluronan-binding proteins: tying up the giant. J. Biol. Chem. 277, 4585-4588.
8. de Belder, A. N. and Wik, K. O. (1975). Preparation and properties of fluorescein-labelled hyaluronate. Carbohydr. Res. 44, 251-257.
9. Filion, M. C. and Phillips, N. C. (2001). Pro-inflammatory activity of contaminating DNA in hyaluronic acid preparations. J. Pharm. Pharmacol. 53, 555-561.
10. Foger, N., Marhaba, R. and Zoller, M. (2001). Involvement of CD44 in cytoskeleton rearrangement and raft reorganization in T cells. J. Cell Sci. 114, 1169-1178.
11. Franzmann, E. J., Schroeder, G. L., Goodwin, W. J., Weed, D. T., Fisher, P. and Lokeshwar, V. B. (2003). Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. Int. J. Cancer 106, 438-445.
12. Gomez-Mouton, C., Lacalle, R. A., Mira, E., Jimenez-Baranda, S., Barber, D. F., Carrera, A. C., Martinez, A. C. and Manes, S. (2004). Dynamic redistribution of raft domains as an organizing platform for signaling during cell chemotaxis. J. Cell Biol. 164, 759-768.
13. Harris, E. N., Weigel, J. A. and Weigel, P H. (2004). Endocytic function, glycosaminoglycan specificity, and antibody sensitivity of the recombinant human 190-kDa hyaluronan receptor for endocytosis (HARE). J. Biol. Chem. 279, 36201-36209.
14. Heldin, P. and Pertoft, H. (1993). Synthesis and assembly of the hyaluronan-containing coats around normal human mesothelial cells. Exp. Cell Res. 208, 422-429.
15. Isacke, C. M., Sauvage, C. A., Hyman, R., Lesley, J., Schulte, R. and Trowbridge, I. S. (1986). Identification and characterization of the human Pgp-1 glycoprotein. Immunogenetics 23, 326-332.
16. Itano, N., Sawai, T, Miyaishi, O. and Kimata, K. (1999). Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res. 59, 2499-2504.
17. Jackson, D. G. (2003). The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1. Trends Cardiovasc. Med. 13, 1-7.
18. Kumar, S., West, D. C., Ponting, J. M. and Gattamaneni, H. R. (1989). Sera of children with renal tumours contain low-molecular-mass hyaluronic acid. Int. J. Cancer 44, 445-448.
19. Laurent, T. C. and Fraser, J. R. (1992). Hyaluronan. FASEB J. 6, 2397-2404.
20. Lee, J. Y. and Spicer, A. P. (2000). Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr. Opin. Cell Biol. 12, 581-586.
21. Lees, V. C., Fan, T. P. and West, D. C. (1995). Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab. Invest. 73, 259-266.
22. Legg, J. W. and Isacke, C. M. (1998). Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44. Curr. Biol. 8, 705-708.
23. Legg, J. W., Lewis, C. A., Parsons, M., Ng, T. and Isacke, C. M. (2002). A novel PKC-regulated mechanism controls CD44 ezrin association and directional cell motility. Nat. Cell. Biol. 4, 399-407.
24. Lesley, J., Hyman, R. and Kincade, P. W. (1993). CD44 and its interaction with extracellular matrix. Adv. Immunol. 54, 271-335.
25. Lesley, J., English, N., Perschl, A., Gregoroff, J. and Hyman, R. (1995). Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med. 182, 431-437.
26. Lesley, J., Hyman, R., English, N., Catterall, J. B. and Turner, G. A. (1997). CD44 in inflammation and metastasis. Glycoconjugate J. 14, 611-622.
27. Lipponen, P., Aaltomaa, S., Tammi, R., Tammi, M., Agren, U. and Kosma, V. M. (2001). High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer. Eur. J. Cancer 37, 849-856.
28. Liu, N., Gao, F., Han, Z., Xu, X., Underhill, C. B. and Zhang, L. (2001). Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Cancer Res. 61, 5207-5214.
29. Lokeshwar, V. B., Rubinowicz, D., Schroeder, G. L., Forgacs, E., Minna, J. D., Block, N. L., Nadji, M. and Lokeshwar, B. L. (2001). Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J. Biol. Chem. 276, 11922-11932.
30. Manes, S., Ana Lacalle, R., Gomez-Mouton, C. and Martinez, A. C. (2003). From rafts to crafts: membrane asymmetry in moving cells. Trends Immunol. 24, 320-326.
31. McKee, C. M., Penno, M. B., Cowman, M., Burdick, M. D., Strieter, R. M., Bao, C. and Noble, P. W. (1996). Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J. Clin. Invest. 98, 2403-2413.
32. Miyake, K., Medina, K. L., Hayashi, S., Ono, S., Hamaoka, T. and Kincade, P. W. (1990). Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. Med. 171, 477-488.
33. Morrison, H., Sherman, L. S., Legg, J., Banine, F., Isacke, C., Haipek, C. A., Gutmann, D. H., Ponta, H. and Herrlich, P. (2001). The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev. 15, 968-980.
34. Neame, S. J., Uff, C. R., Sheikh, H., Wheatley, S. C. and Isacke, C. M. (1995). CD44 exhibits a cell type dependent interaction with triton X-100 insoluble, lipid rich, plasma membrane domains. J. Cell Sci. 108, 3127-3135.
35. Noble, P. W. (2002). Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 21, 25-29.
36. Oliferenko, S., Paiha, K., Harder, T., Gerke, V., Schwarzler, C., Schwarz, H., Beug, H., Gunthert, U. and Huber, L. A. (1999). Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton. J. Cell Biol. 146, 843-854.
37. Peach, R. J., Hollenbaugh, D., Stamenkovic, I. and Aruffo, A. (1993). Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122, 257-264.
38. Peck, D. and Isacke, C. M. (1996). CD44 phosphorylation regulates melanoma cell and fibroblast migration on, but not attachment to, a hyaluronan substratum. Curr. Biol. 6, 884-890.
39. Perschl, A., Lesley, J., English, N., Hyman, R. and Trowbridge, I. S. (1995a). Transmembrane domain of CD44 is required for its detergent insolubility in fibroblasts. J. Cell Sci. 108, 1033-1041.
40. Perschl, A., Lesley, J., English, N., Trowbridge, I. and Hyman, R. (1995b). Role of CD44 cytoplasmic domain in hyaluronan binding. Eur. J. Immunol. 25, 495-501.
41. Politz, O., Gratchev, A., McCourt, P. A., Schledzewski, K., Guillot, P., Johansson, S., Svineng, G., Franke, P., Kannicht, C., Kzhyshkowska, J. et al. (2002). Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem. J. 362, 155-164.
42. Ponta, H., Sherman, L. and Herrlich, P. A. (2003). CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell. Biol. 4, 33-45.
43. Prevo, R., Banerji, S., Ferguson, D. J., Clasper, S. and Jackson, D. G. (2001). Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J. Biol. Chem. 276, 19420-19430.
44. Rooney, P., Kumar, S., Ponting, J. and Wang, M. (1995). The role of hyaluronan in tumour neovascularization (review). Int. J. Cancer 60, 632-636.
45. Roscic-Mrkic, B., Fischer, M., Leemann, C., Manrique, A., Gordon, C. J., Moore, J. P., Proudfoot, A. E. and Trkola, A. (2003). RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement. Blood 102, 1169-1177.
46. Shuster, S., Frost, G. I., Csoka, A. B., Formby, B. and Stern, R. (2002). Hyaluronidase reduces human breast cancer xenografts in SCID mice. Int. J. Cancer 102, 192-197.
47. Simpson, M. A., Wilson, C. M. and McCarthy, J. B. (2002). Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. Am. J. Pathol. 161, 849-857.
48. Skelton, T. P., Zeng, C., Nocks, A. and Stamenkovic, I. (1998). Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J. Cell Biol. 140, 431-446.
49. Spicer, A. P. and McDonald, J. A. (1998). Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J. Biol. Chem. 273, 1923-1932.
50. Stamenkovic, L., Aruffo, A., Amiot, M. and Seed, B. (1991). The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J. 10, 343-348.
51. Stern, R. (2003). Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology 13, 105R-115R.
52. Sturge, J., Hamelin, J. and Jones, G. E. (2002). N-WASP activation by a beta 1-integrin-dependent mechanism supports P13K-independent chemotaxis stimulated by urokinase- type plasminogen activator. J. Cell Sci. 115, 699-711.
53. Sugahara, K. N., Murai, T., Nishinakamura, H., Kawashima, H., Saya, H. and Miyasaka, M. (2003). Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J. Biol. Chem. 278, 32259-32265.
54. Sullivan, A., Uff, C. R., Isacke, C. M. and Thorne, R. F. (2003). PACE-1, a novel protein that interacts with the C-terminal domain of ezrin. Exp. Cell Res. 284, 224-238.
55. Tammi, R., MacCallum, D., Hascall, V. C., Pienimaki, J. P., Hyttinen, M. and Tammi, M. (1998). Hyaluronan bound to CD44 on keratinocytes is displaced by hyaluronan decasaccharides and not hexasaccharides. J. Biol. Chem. 273, 28878-28888.
56. Tammi, M. I., Day, A. J. and Turley, E. A. (2002). Hyaluronan and homeostasis: a balancing act. J. Biol. Chem. 277, 4581-4584.
57. Taylor, K. R., Trowbridge, J. M., Rudisill, J. A., Termeer, C. C., Simon, J. C. and Gallo, R. L. (2004). Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279, 17079-17084.
58. Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C. and Simon, J. C. (2002). Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195, 99-111.
59. Thorne, R. F., Marshall, J. F., Shafren, D. R., Gibson, P. G., Hart, I. R. and Burns, G. F. (2000). The integrins alpha3beta1 and alpha6beta1 physically and functionally associate with CD36 in human melanoma cells. Requirement for the extracellular domain of CD36. J. Biol. Chem. 275, 35264-35275.
60. Thorne, R. F., Legg, J. W. and Isacke, C. M. (2004). The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events. J. Cell Sci. 117, 373-378.
61. Toole, B. P. (2004). Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 4, 528-539.
62. Toole, B. P., Wight, T. N. and Tammi, M. I. (2002). Hyaluronan-cell interactions in cancer and vascular disease. J. Biol. Chem. 277, 4593-4596.
63. Trowbridge, I. S., Lesley, J., Schulte, R., Hyman, R. and Trotter, J. (1982). Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics 15, 299-312.
64. Turley, E. A., Noble, P. W. and Bourguignon, L. Y. (2002). Signaling properties of hyaluronan receptors. J. Biol. Chem. 277, 4589-4592.
65. Tzircotis, G., Thorne, R. F. and Isacke, C. M. (2004). A new spreadsheet method for the analysis of bivariate flow cytometric data. BMC Cell Biol. 5, 10.
66. Uff, C. R., Neame, S. J. and Isacke, C. M. (1995). Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism. Eur J. Immunol. 25, 1883-1887.
67. West, D. C., Hampson, I. N., Arnold, F. and Kumar, S. (1985). Angiogenesis induced by degradation products of hyaluronic acid. Science 228, 1324-1326.
68. Wienke, D., MacFadyen, J. R. and Isacke, C. M. (2003). Identification and characterization of the endocytic transmembrane glycoprotein Endo180 as a novel collagen receptor. Mol. Biol. Cell 14, 3592-3604.
69. Yonemura, S., Hirao, M., Doi, Y., Takahashi, N., Kondo, T. and Tsukita, S. (1998). Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J. Cell Biol. 140, 885-895.
70. Zicha, D. and Dunn, G. A. (1995). Are growth factors chemotactic agents? Exp. Cell Res. 221, 526-529.